James Stephen Kowszun

James, prior to joining the Group, was Finance Director of the SFI Group plc from August 2000 until April 2002.
He was previously Finance Director of The Slug and Lettuce Group Limited from January 2000 until its takeover by the SFI Group in August 2000.
Prior to this, he was the Finance Director of Allergy Therapeutics Limited a management buy-in out from SmithKline Beecham Plc.
He was previously at Bass Brewers Ltd, where he was a member of the strategic planning team, working on a number of high profile strategic projects one of which was the proposed acquisition of Carlsberg-Tetley Plc (eventually blocked by the Monopolies and Merger Commission).
Prior to this, he worked at SmithKline Beecham Plc, initially in group finance and latterly in corporate development handling transactions including the acquisition of Sterling Health and the disposal of the Global Animal Health Division.
James qualified as a chartered accountant with Arthur Andersen (1992), where he specialised in corporate recovery.